Italy Exosomes Market Size & Outlook, 2023-2030
Italy exosomes market, 2018-2030 (US$M)
Related Markets
Italy exosomes market highlights
- The Italy exosomes market generated a revenue of USD 2.6 million in 2023 and is expected to reach USD 17.3 million by 2030.
- The Italy market is expected to grow at a CAGR of 31.2% from 2024 to 2030.
- In terms of segment, kits & reagents was the largest revenue generating product in 2023.
- Kits & Reagents is the most lucrative product segment registering the fastest growth during the forecast period.
Exosomes market data book summary
| Market revenue in 2023 | USD 2.6 million |
| Market revenue in 2030 | USD 17.3 million |
| Growth rate | 31.2% (CAGR from 2023 to 2030) |
| Largest segment | Kits & reagents |
| Fastest growing segment | Kits & Reagents |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Kits & Reagents, Instruments, Services |
| Key market players worldwide | Danaher Corp, Hologic Inc, FUJIFILM Holdings Corp, Lonza Group Ltd, Miltenyi Biotec, Bio-Techne Corp, Qiagen NV, Thermo Fisher Scientific Inc, Abcam PLC, RoosterBio |
Other key industry trends
- In terms of revenue, Italy accounted for 1.8% of the global exosomes market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany exosomes market is projected to lead the regional market in terms of revenue in 2030.
- UK is the fastest growing regional market in Europe and is projected to reach USD 54.7 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Exosomes Market Scope
Exosomes Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Italy exosomes market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to exosomes market will help companies and investors design strategic landscapes.
Kits & reagents was the largest segment with a revenue share of 46.15% in 2023. Horizon Databook has segmented the Italy exosomes market based on kits & reagents, instruments, services covering the revenue growth of each sub-segment from 2018 to 2030.
Establishment of companies that are engaged in exosomes-based R&D is the key contributing factor to the revenue generated by Italy in the global market. For instance, Hansa BioMed Life Sciences Ltd is entirely focused on the research pertaining to exosome and development of exosome products.
Hansa BioMed Life Sciences is now a part of Lonza and offers its exosomes-related products as well as services in Italy through DBA Italia srl. In addition, Exosomics S.p.A is another such biotechnology company located in Siena, Italy that is completely dedicated to the development of exosomes-related products.
The company is focused on developing and commercializing next-generation tests suitable for liquid biopsy and cancer screening; these tests are being developed by analyzing exosomes. Furthermore, the company also announced the launch of its first exosomes-based liquid biopsy products, namely Sort EV RNA and Sele CTEV DNA.
Reasons to subscribe to Italy exosomes market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Italy exosomes market databook
-
Our clientele includes a mix of exosomes market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Italy exosomes market , including forecasts for subscribers. This country databook contains high-level insights into Italy exosomes market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Italy exosomes market size, by product, 2018-2030 (US$M)
Italy Exosomes Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
